Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on March 31, 2020. The report announces consolidated financial results for the third quarter and the first nine months of fiscal 2020, which ended on February 23, 2020.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that the results have been issued via a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation (LNDC), not Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (Press Release dated March 31, 2020) for actual financial figures and operational details.
- Confirm the fiscal period covered is the third quarter and first nine months ended February 23, 2020.
- Note that this 8-K is a notification of results rather than a detailed financial statement.